Literature DB >> 15501776

Role of protein tyrosine kinase p53/56lyn in diminished lipopolysaccharide priming of formylmethionylleucyl- phenylalanine-induced superoxide production in human newborn neutrophils.

Sen Rong Yan1, David M Byers, Robert Bortolussi.   

Abstract

Human newborns are more susceptible than adults to bacterial infection. With gram-negative bacteria, this may be due to a diminished response of newborn leukocytes to lipopolysaccharide (LPS). Since protein tyrosine kinase inhibition abolishes LPS priming in adult cells, we hypothesized that protein tyrosine kinases may have a critical role in LPS priming of polymorphonuclear neutrophils (PMNs) and that newborn PMNs may have altered protein tyrosine kinase activities. In the present study, we investigated the role of src family protein tyrosine kinases in the LPS response of newborn PMNs compared to adult cells. In a respiratory assay, the LPS-primed increase in formylmethionylleucylphenylalanine (fMLP)-triggered O2- release by adult PMNs was greatly decreased by PP1 [4-amino-5-(4-methyphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine], a src kinase inhibitor, to the level of untreated newborn PMNs, in which LPS failed to prime. LPS activated the src-like kinases p59hck (HCK) and p58fgr (FGR) in both adult and newborn PMNs but increased the activation of p53/56lyn (LYN) only in adult cells. In newborn PMNs, LYN was highly phosphorylated independent of LPS. We evaluated subcellular fractions of PMNs and found that the phosphorylated form of LYN was mainly in the Triton-extractable, cytosolic fraction in adult PMNs, while in newborn cells it was located mainly in Triton-insoluble, granule- and membrane-associated fractions. In contrast, the phosphorylated mitogen-activated protein kinases ERK1/2 and p38 were mainly detected in the cytosol in both adult and newborn PMNs. These data indicate a role for LYN in the regulation of LPS priming. The trapping of phosphorylated LYN in the membrane-granule fraction in newborn PMNs may contribute to the deficiency of newborn cells in responding to LPS stimulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501776      PMCID: PMC523037          DOI: 10.1128/IAI.72.11.6455-6462.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Priming-induced localization of G(ialpha2) in high density membrane microdomains.

Authors:  Michael L Keil; Naveenraj L Solomon; Irfan J Lodhi; Kimberley C Stone; Algirdas J Jesaitis; Peter S Chang; Jennifer J Linderman; Geneva M Omann
Journal:  Biochem Biophys Res Commun       Date:  2003-02-21       Impact factor: 3.575

2.  Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation.

Authors:  V W Chan; F Meng; P Soriano; A L DeFranco; C A Lowell
Journal:  Immunity       Date:  1997-07       Impact factor: 31.745

Review 3.  Lyn, a src-like tyrosine kinase.

Authors:  M L Hibbs; A R Dunn
Journal:  Int J Biochem Cell Biol       Date:  1997-03       Impact factor: 5.085

4.  Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.

Authors:  E Lien; T K Means; H Heine; A Yoshimura; S Kusumoto; K Fukase; M J Fenton; M Oikawa; N Qureshi; B Monks; R W Finberg; R R Ingalls; D T Golenbock
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

5.  G-protein-coupled receptor signaling in Syk-deficient neutrophils and mast cells.

Authors:  Attila Mócsai; Hong Zhang; Zoltán Jakus; Jiro Kitaura; Toshiaki Kawakami; Clifford A Lowell
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

6.  Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes.

Authors:  Thomas Nebl; Kersi N Pestonjamasp; John D Leszyk; Jessica L Crowley; Sang W Oh; Elizabeth J Luna
Journal:  J Biol Chem       Date:  2002-08-28       Impact factor: 5.157

7.  The Lyn tyrosine kinase negatively regulates neutrophil integrin signaling.

Authors:  Shalini Pereira; Clifford Lowell
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

8.  Impaired CD14-dependent and independent response of polymorphonuclear leukocytes in preterm infants.

Authors:  Philipp Henneke; Inga Osmers; Karl Bauer; Norbert Lamping; Hans T Versmold; Ralf R Schumann
Journal:  J Perinat Med       Date:  2003       Impact factor: 1.901

9.  Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response.

Authors:  Matthias Ernst; Melissa Inglese; Glen M Scholz; Kenneth W Harder; Fiona J Clay; Steven Bozinovski; Paul Waring; Rima Darwiche; Tom Kay; Peter Sly; Rachel Collins; Debra Turner; Margaret L Hibbs; Gary P Anderson; Ashley R Dunn
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

10.  Beta 2 integrin-dependent protein tyrosine phosphorylation and activation of the FGR protein tyrosine kinase in human neutrophils.

Authors:  G Berton; L Fumagalli; C Laudanna; C Sorio
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

View more
  4 in total

1.  Neonatal sepsis and neutrophil insufficiencies.

Authors:  John Nicholas Melvan; Gregory J Bagby; David A Welsh; Steve Nelson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2010-06       Impact factor: 5.311

2.  Flice inhibitory protein is associated with the survival of neonatal neutrophils.

Authors:  Ramachandran Rashmi; Patricia M Schnulle; Allison C Maddox; Eric S Armbrecht; Joyce M Koenig
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

3.  Siglec-9 and SHP-1 are differentially expressed in neonatal and adult neutrophils.

Authors:  Ramachandran Rashmi; Barrie P Bode; Ninder Panesar; Sarah B King; James R Rudloff; Melisa R Gartner; Joyce M Koenig
Journal:  Pediatr Res       Date:  2009-09       Impact factor: 3.756

Review 4.  Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines.

Authors:  Peter Klein Klouwenberg; Louis Bont
Journal:  Clin Dev Immunol       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.